
Keywords: FDA، اداره غذا و دارو ایالات متحده; FDA, U.S. Food and Drug Administration; TBI, traumatic brain injury; NAM, nicotinamide; PARP, poly(ADP-ribose)polymerase-1; NAD+, nicotinamide-adenine dinucleotide; ATP, adenosine triphosphate; DNA, deoxyribonucleic acid; PLP, pyridoxal 5′-phosphate; MWM,